What is Max Healthcare Institute Ltd (MAXHEALTH) share price today?

Max Healthcare Institute Ltd (MAXHEALTH) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/MAXHEALTH for the latest live price, technical analysis, and AI-powered insights.

How to analyse MAXHEALTH stock?

VestAI provides comprehensive MAXHEALTH stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Max Healthcare Institute Ltd in?

Max Healthcare Institute Ltd (MAXHEALTH) is in the Healthcare sector, Hospital industry on the NSE.

Max Healthcare Institute Ltd

Name: Max Healthcare Institute Ltd (MAXHEALTH) Financial Metrics
Creator: VestAI

MAXHEALTH

NSE· Healthcare

₹1,102.40

+12.50 (+1.15%)

Updated 10:16 am IST

52W Low · ₹903.0052W High · ₹1,301.70

Mid Range

Market Cap

₹95110.25L Cr

Volume

9.91L

Prev Close

₹1,098.20

ISIN

INE027H01010

Orion Score

Fundamentals-based quality & risk · not a recommendation

67/100

Quality

Max Healthcare Institute Ltd scores 67/100 (Quality) on the Orion Score — strong business quality (71), strong growth (96), moderate balance-sheet safety (67) and rich valuation (15). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.2× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 4/9Altman Z Safe(5.20)Beneish M Elevated(-1.80)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

63/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.32x — lean balance sheet

QUALITY

Average

ROCE 11.9% — decent returns

MOMENTUM

Neutral

RSI 51.7 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 66.21
ROCE: 11.94%
ROE (1Y): 14.33%
D/E Ratio: 0.32x
OPM: 22.56%
TTM EPS: ₹14.76
Dividend Yield: 15.00%
Qtrly Sales: ₹2,142.89 Cr
Qtrly Profit: ₹342.22 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹2,142.89	₹342.22	22.6%	₹3.50
Q3 2026	₹2,067.52	₹300.92	20.7%	₹3.09
Q2 2026	₹2,135.47	₹491.3	21.9%	₹5.02
Q1 2026	₹2,027.57	₹307.97	20.6%	₹3.15
Q4 2025	₹1,909.74	₹319	21.5%	₹3.26

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2025	₹6,910.36	₹1,075.88	₹1,914.54	22.8%
FY 2024	₹5,309.48	₹1,057.64	₹1,654.86	24.2%
FY 2023	₹4,488.95	₹1,103.51	₹1,367.23	23.3%
FY 2022	₹3,883.19	₹605.05	₹1,050.03	20.4%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
MAXHEALTH ★	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
CIPLACipla Limited	₹1,14,609 Cr	29.76	13.66%	11.74%	0.02x	9.50%
AUROPHARMAAurobindo Pharma Limited	₹88,228 Cr	25.64	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹71,372 Cr	108.60	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,615 Cr	38.42	36.14%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹15,214.48	₹11,999.94	₹10,101.85	₹9,189.13
Equity	₹9,380.87	₹8,408.14	₹7,409.59	₹6,282.47
Total Debt	₹3,010.29	₹1,294.56	₹908.25	₹1,138.62
Cash	₹661.58	₹979.84	₹1,374.33	₹309.14
Net Debt	₹1,827.25	₹165.39	₹522.07	₹417.51
Working Capital	₹-221.2	₹457.47	₹897.5	₹243.02

Shareholding Pattern

Q1 FY2027

Promoter

26.51%

FII

29.92%

DII

24.48%

Public

19.09%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	26.51% ↑	29.92% ↓	24.48% ↑	19.09% ↑
Q3 FY2026	23.72% ↓	50.55% ↓	21.2% ↑	4.52% ↑
Q2 FY2026	23.74%	51.8% ↓	20.03% ↑	4.43% ↑
Q1 FY2026	23.74%	54.76% ↑	17.41% ↓	4.09% ↑
Q4 FY2025	23.74%	54.74% ↓	17.59% ↑	3.94% ↑
Q3 FY2025	23.74%	56.93% ↓	15.55% ↑	3.77% ↓
Q2 FY2025	23.74%	57.29% ↑	15.14% ↓	3.84% ↓
Q1 FY2025	23.74%	56.99%	15.36%	3.91%

Corporate Actions

Ex-Date	Action	Details
2026-07-03	DIVIDEND	Dividend - Rs 2 Per Share

Smart Money Holdings

Q4 FY2025

Investor	Shares Held	Portfolio %	Change
capital-group	—	—	—

Funds Holding This Stock

242 mutual fund schemes

DSP Nifty Healthcare Index Fund Direct GrowthDSP

6.89%

₹1 Cr

Invesco India Large & Mid Cap Fund Direct GrowthINVESCO

6.77%

₹757 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

6.29%

₹20 Cr

Invesco India Business Cycle Fund Direct GrowthINVESCO

5.49%

₹66 Cr

Kotak Healthcare Fund Direct GrowthKOTAK_MAHINDRA

5.43%

₹30 Cr

HDFC Pharma And Healthcare Fund Direct GrowthHDFC

5.26%

₹124 Cr

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct GrowthEDELWEISS

4.97%

₹9 Cr

PGIM India Healthcare Fund Direct GrowthDHFL_PRAMERICA

4.97%

₹5 Cr

ITI Pharma and Healthcare Fund Direct GrowthITI

4.90%

₹12 Cr

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

4.86%

₹1 Cr

Analyse MAXHEALTH with Orion AI

Ask: "Is Max Healthcare Institute Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Max Healthcare Institute Ltd (MAXHEALTH) Stock

Max Healthcare Institute Ltd is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE027H01010. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.